Precision probiotics firm Biome Australia says that giving practitioners a foundational understanding of microbiome modulation, before reinforcing efficacy via clinical trials, will be key to its ongoing growth objectives in the market.
BIO & ME, the consumer health brand of Singapore-based gut microbiome firm AMILI, has launched five probiotic formulations to target immunity, well-being, energy, mental health and strength – all tailored to the Asian population.